Atrial fibrillation trials recruiting in Louisiana

All Atrial fibrillation trials nationally

Cities in Louisiana

Recruiting trials in Louisiana

• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
  NCT04045665 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Louisiana: New Orleans
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
  NCT03907046 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Louisiana: New Orleans
• Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study
  NCT04814420 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Louisiana: New Orleans
• Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
  NCT05014802 · Phase: Not specified · Ages: 40 Years to 120 Years · Sex: All (male and female) · Louisiana: Covington, New Orleans
• Detection of Atrial Fibrillation Using PPG From Smartphone Cameras
  NCT07779213 · Phase: Not specified · Ages: 22 Minutes and older · Sex: All (male and female) · Louisiana: New Orleans
• Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology
  NCT06753045 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · Louisiana: New Orleans
• STOP AF First Post-Approval Study
  NCT05227053 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Louisiana: Baton Rouge
• Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
  NCT07175428 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Louisiana: West Monroe
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
  NCT07626411 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Louisiana: West Monroe
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
  NCT07430956 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Louisiana: West Monroe
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female) · Louisiana: Alexandria, Eunice, Shreveport, West Monroe
• The CoAGulation Biomarkers and Atrial Fibrillation (COAG-AF) Pilot Study
  NCT04947657 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · Louisiana: New Orleans
• The Fourth Left Atrial Appendage Occlusion Study
  NCT05963698 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Louisiana: New Orleans
• Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.
  NCT04703166 · Phase: Not specified · Ages: 18 Years to 79 Years · Sex: All (male and female) · Louisiana: New Orleans